Decreased isavuconazole trough concentrations in the treatment of invasive aspergillosis in an adult patient receiving extracorporeal membrane oxygenation support
暂无分享,去创建一个
[1] Arun Chopra,et al. Oxygenator impact on voriconazole in extracorporeal membrane oxygenation circuits , 2020, Perfusion.
[2] A. Oulhaj,et al. Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations , 2020, Journal of fungi.
[3] A. Borman,et al. Lessons from isavuconazole therapeutic drug monitoring at a United Kingdom Reference Center. , 2020, Medical mycology.
[4] E. Barreto,et al. Altered Pharmacokinetics and Dosing of Liposomal Amphotericin B and Isavuconazole during Extracorporeal Membrane Oxygenation , 2019, Pharmacotherapy.
[5] C. Viscoli,et al. Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy. , 2019, The Journal of antimicrobial chemotherapy.
[6] L. Millon,et al. The pharmacokinetic challenge of treating invasive aspergillosis complicating severe influenzae assisted by extracorporeal membrane oxygenation , 2018, Critical Care.
[7] T. Walsh,et al. Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials , 2018, Antimicrobial Agents and Chemotherapy.
[8] J. Roberts,et al. Optimising drug dosing in patients receiving extracorporeal membrane oxygenation. , 2018, Journal of thoracic disease.
[9] P. Bonate,et al. Population Pharmacokinetics of Isavuconazole from Phase 1 and Phase 3 (SECURE) Trials in Adults and Target Attainment in Patients with Invasive Infections Due to Aspergillus and Other Filamentous Fungi , 2016, Antimicrobial Agents and Chemotherapy.
[10] John F. Fraser,et al. Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models , 2015, Critical Care.
[11] J. Fraser,et al. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. , 2012, Journal of critical care.
[12] P. Annaert,et al. Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation. , 2009, The Journal of antimicrobial chemotherapy.
[13] J. Arnold,et al. Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment , 2007, Intensive Care Medicine.